Dow Jones

44,722.06

-0.31%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

LUNG

Pulmonx (LUNG)

Pulmonx Corporation

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:LUNG

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
26/11/2024	17:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUNG	Pulmonx Corporation
22/11/2024	15:28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LUNG	Pulmonx Corporation
20/11/2024	15:05	GlobeNewswire Inc.	Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference	NASDAQ:LUNG	Pulmonx Corporation
19/11/2024	08:00	Business Wire	Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers	NASDAQ:LUNG	Pulmonx Corporation
14/11/2024	18:47	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:LUNG	Pulmonx Corporation
07/11/2024	15:05	GlobeNewswire Inc.	Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum	NASDAQ:LUNG	Pulmonx Corporation
05/11/2024	15:05	GlobeNewswire Inc.	Pulmonx to Present at the Stifel 2024 Healthcare Conference	NASDAQ:LUNG	Pulmonx Corporation
01/11/2024	15:23	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LUNG	Pulmonx Corporation
30/10/2024	15:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUNG	Pulmonx Corporation
30/10/2024	15:05	GlobeNewswire Inc.	Pulmonx Reports Third Quarter 2024 Financial Results	NASDAQ:LUNG	Pulmonx Corporation
16/10/2024	15:05	GlobeNewswire Inc.	Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024	NASDAQ:LUNG	Pulmonx Corporation
09/09/2024	15:05	GlobeNewswire Inc.	Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024	NASDAQ:LUNG	Pulmonx Corporation
29/08/2024	15:05	GlobeNewswire Inc.	Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference	NASDAQ:LUNG	Pulmonx Corporation
22/08/2024	15:05	GlobeNewswire Inc.	Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference	NASDAQ:LUNG	Pulmonx Corporation
31/07/2024	15:05	GlobeNewswire Inc.	Pulmonx Reports Second Quarter 2024 Financial Results	NASDAQ:LUNG	Pulmonx Corporation
29/07/2024	15:05	GlobeNewswire Inc.	Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference	NASDAQ:LUNG	Pulmonx Corporation
10/07/2024	15:05	GlobeNewswire Inc.	Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024	NASDAQ:LUNG	Pulmonx Corporation
31/05/2024	15:38	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NASDAQ:LUNG	Pulmonx Corporation
06/05/2024	16:03	GlobeNewswire Inc.	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:LUNG	Pulmonx Corporation
01/05/2024	15:05	GlobeNewswire Inc.	Pulmonx Reports First Quarter 2024 Financial Results	NASDAQ:LUNG	Pulmonx Corporation
10/04/2024	15:05	GlobeNewswire Inc.	Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024	NASDAQ:LUNG	Pulmonx Corporation
02/04/2024	15:05	GlobeNewswire Inc.	Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer	NASDAQ:LUNG	Pulmonx Corporation
07/03/2024	19:02	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:LUNG	Pulmonx Corporation
29/02/2024	15:31	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:LUNG	Pulmonx Corporation
27/02/2024	15:07	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:LUNG	Pulmonx Corporation
26/02/2024	19:48	Business Wire	Pulmonx meldet Behandlung des ersten Patienten mit dem AeriSeal®-System in der CONVERT-II-Zulassungsstudie	NASDAQ:LUNG	Pulmonx Corporation
26/02/2024	19:40	Business Wire	Pulmonx annonce le traitement du premier patient par système AeriSeal® dans l'essai pivot CONVERT II	NASDAQ:LUNG	Pulmonx Corporation
26/02/2024	19:39	Business Wire	Pulmonx annuncia il trattamento del primo paziente con il sistema AeriSeal® nello studio pivotale CONVERT II	NASDAQ:LUNG	Pulmonx Corporation
26/02/2024	07:00	Business Wire	Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial	NASDAQ:LUNG	Pulmonx Corporation
21/02/2024	15:06	GlobeNewswire Inc.	Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:LUNG	Pulmonx Corporation